Kimia Biosciences share news, announcements and annual reports
BSE: 530313Pharmaceuticals & BiotechnologySmall Cap
KIMIA BIOSCIENCES LIMITED · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1995
Last close ₹30.25down ₹0.57 (1.85%)
Share price at the BSE close on 28 Oct 2026. Previous close ₹30.82.
28 Oct: open ₹30.20, high ₹30.27, low ₹28.50
52-week range of traded prices to 28 Oct 2026
₹23.20Low, 30 Mar 2026₹43.28High, 16 Feb 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹143 Cr2,580th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 19.92
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 8.08
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 51.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 19.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 1.95
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 3,766
Kimia Biosciences board meetings
134 filed, newest first. Page 3 of 3.
Aug 2020
Jun 2020
15 Jun · Board meeting
Meeting on 26 Jun 2020: audited results
Feb 2020
13 Feb · Board meeting
1 Feb · Board meeting
Meeting on 13 Feb 2020: quarterly results
Oct 2019
11 Oct · Board meeting
Meeting on 24 Oct 2019: quarterly results7 Oct · Board meeting
Aug 2019
26 Aug · Board meeting
Jul 2019
29 Jul · Board meeting
Meeting on 12 Aug 2019: quarterly results
Jun 2019
May 2019
8 May · Board meeting
Meeting on 22 May 2019: audited results
Feb 2019
1 Feb · Board meeting
Meeting on 11 Feb 2019: quarterly results
Dec 2018
21 Dec · Board meeting
Oct 2018
Aug 2018
May 2018
25 May · Board meeting
Feb 2018
15 Feb · Board meeting
9 Feb · Board meeting
Dec 2017
21 Dec · Board meeting
May 2017
Nov 2016
Aug 2016
May 2016
Mar 2016